195 related articles for article (PubMed ID: 12827452)
1. A mutation analysis of the BRCA1 gene in 140 families from southeast France with a history of breast and/or ovarian cancer.
Rostagno P; Gioanni J; Garino E; Vallino P; Namer M; Frenay M
J Hum Genet; 2003; 48(7):362-6. PubMed ID: 12827452
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.
Stoppa-Lyonnet D; Laurent-Puig P; Essioux L; Pagès S; Ithier G; Ligot L; Fourquet A; Salmon RJ; Clough KB; Pouillart P; Bonaïti-Pellié C; Thomas G
Am J Hum Genet; 1997 May; 60(5):1021-30. PubMed ID: 9150149
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.
Vallon-Christersson J; Cayanan C; Haraldsson K; Loman N; Bergthorsson JT; Brøndum-Nielsen K; Gerdes AM; Møller P; Kristoffersson U; Olsson H; Borg A; Monteiro AN
Hum Mol Genet; 2001 Feb; 10(4):353-60. PubMed ID: 11157798
[TBL] [Abstract][Full Text] [Related]
4. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
Hamann U; Brauch H; Garvin AM; Bastert G; Scott RJ
Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
[TBL] [Abstract][Full Text] [Related]
5. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.
Ikeda N; Miyoshi Y; Yoneda K; Shiba E; Sekihara Y; Kinoshita M; Noguchi S
Int J Cancer; 2001 Jan; 91(1):83-8. PubMed ID: 11149425
[TBL] [Abstract][Full Text] [Related]
6. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
Meyer P; Voigtlaender T; Bartram CR; Klaes R
Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.
Meindl A;
Int J Cancer; 2002 Feb; 97(4):472-80. PubMed ID: 11802209
[TBL] [Abstract][Full Text] [Related]
8. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.
Serova O; Montagna M; Torchard D; Narod SA; Tonin P; Sylla B; Lynch HT; Feunteun J; Lenoir GM
Am J Hum Genet; 1996 Jan; 58(1):42-51. PubMed ID: 8554067
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan.
Takano M; Aida H; Tsuneki I; Takakuwa K; Hasegawa I; Tanaka H; Saito M; Tsuji S; Sonoda T; Hatae M; Chen JT; Takahashi K; Hasegawa K; Toyoda N; Saito N; Yakushiji M; Araki T; Tanaka K
Jpn J Cancer Res; 1997 Apr; 88(4):407-13. PubMed ID: 9197534
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
Kim TJ; Lee KM; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
Oncol Rep; 2006 Mar; 15(3):565-9. PubMed ID: 16465413
[TBL] [Abstract][Full Text] [Related]
12. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families.
Phelan CM; Kwan E; Jack E; Li S; Morgan C; Aubé J; Hanna D; Narod SA
Hum Mutat; 2002 Nov; 20(5):352-7. PubMed ID: 12402332
[TBL] [Abstract][Full Text] [Related]
13. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
14. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
15. Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families.
Hamann U; Häner M; Stosiek U; Bastert G; Scott RJ
J Med Genet; 1997 Nov; 34(11):884-8. PubMed ID: 9391879
[TBL] [Abstract][Full Text] [Related]
16. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
Ganguly T; Dhulipala R; Godmilow L; Ganguly A
Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer.
Hansen TV; Jønson L; Albrechtsen A; Steffensen AY; Bergsten E; Myrhøj T; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2010 Nov; 124(1):259-64. PubMed ID: 20437199
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
19. A high proportion of mutations in the BRCA1 gene in German breast/ovarian cancer families with clustering of mutations in the 3' third of the gene.
Dong J; Chang-Claude J; Wu Y; Schumacher V; Debatin I; Tonin P; Royer-Pokora B
Hum Genet; 1998 Aug; 103(2):154-61. PubMed ID: 9760198
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).
Willems P; Magri V; Cretnik M; Fasano M; Jakubowska A; Levanat S; Lubinski J; Marras E; Musani V; Thierens H; Vandersickel V; Perletti G; Vral A
Int J Oncol; 2009 Apr; 34(4):1005-15. PubMed ID: 19287957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
